These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8787243)

  • 21. [Experimental models of amyotrophic lateral sclerosis].
    Galán L; Vela A; Guerrero A; Barcia JA; García-Verdugo JM; Matias-Guiu J
    Neurologia; 2007; 22(6):381-8. PubMed ID: 17610166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Antibody titers to coxsackieviruses in amyotrophic lateral sclerosis.
    Cremer NE; Norris FH; Shinomoto T; Lennette EH
    N Engl J Med; 1976 Jul; 295(2):107-8. PubMed ID: 1272306
    [No Abstract]   [Full Text] [Related]  

  • 23. Lyophilized red wine administration prolongs survival in an animal model of amyotrophic lateral sclerosis.
    Esposito E; Rossi C; Amodio R; Di Castelnuovo A; Bendotti C; Rotondo T; Algeri S; Rotilio D
    Ann Neurol; 2000 Oct; 48(4):686-7. PubMed ID: 11026458
    [No Abstract]   [Full Text] [Related]  

  • 24. [HLA and amyotrophic lateral sclerosis].
    Májský A; Nevsímal O; Süssová J
    Cesk Neurol Neurochir; 1983 May; 46(3):176-8. PubMed ID: 6872062
    [No Abstract]   [Full Text] [Related]  

  • 25. A molecular genetic approach to amyotrophic lateral sclerosis.
    Siddique T; Hu P; Hentati A; Deng G; Hung WY; McInnis MG; Warren AC; Rimmler J; Antonarakis S; Pericak-Vance MA
    Int J Neurol; 1991-1992; 25-26():60-9. PubMed ID: 11980064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is prostaglandin E(2) a pathogenic factor in amyotrophic lateral sclerosis?
    Almer G; Kikuchi H; Teismann P; Przedborski S
    Ann Neurol; 2006 Jun; 59(6):980-3. PubMed ID: 16619237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lyme disease serology in amyotrophic lateral sclerosis.
    Qureshi M; Bedlack RS; Cudkowicz ME
    Muscle Nerve; 2009 Oct; 40(4):626-8. PubMed ID: 19697382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comment on: "Follow-up study of hyperimmune goat serum (AIMSPRO) for amyotrophic lateral sclerosis".
    Day TJ
    J Clin Neurosci; 2009 Nov; 16(11):1509-11. PubMed ID: 19695881
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hope for amyotrophic lateral sclerosis?].
    Jokelainen M
    Duodecim; 1994; 110(16):1499-501. PubMed ID: 7497973
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply to "Comment on: 'Follow-up study of hyperimmune goat serum (AIMSPRO) for amyotrophic lateral sclerosis'".
    Mackenzie RA
    J Clin Neurosci; 2010 Mar; 17(3):412-3. PubMed ID: 20083409
    [No Abstract]   [Full Text] [Related]  

  • 31. The possible role of a secondary pathogenetic factor in amyotrophic lateral sclerosis.
    Pinelli P; Pisano F; Miscio G
    Adv Neurol; 1995; 68():29-40. PubMed ID: 8787240
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosuppression and anti-inflammatory agents in ALS.
    Smith RG; Appel SH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Dec; 1 Suppl 4():33-42; discussion 42-3. PubMed ID: 11466958
    [No Abstract]   [Full Text] [Related]  

  • 33. Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?
    Staines DR
    Med Hypotheses; 2008; 70(2):413-8. PubMed ID: 17582695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amyotrophic lateral sclerosis and anti-CV2 antibodies. Paraneoplastic association?].
    García Martín G; Perez Errazquin F; Chamorro Muñoz M; Romero Acebal M
    Neurologia; 2007; 22(6):406-9. PubMed ID: 17610172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
    Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skeletal muscle in amyotrophic lateral sclerosis: emerging concepts and therapeutic implications.
    Abmayr S; Weydt P
    Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):1091-7, xi-xii. PubMed ID: 16214062
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperimmune goat serum for amyotrophic lateral sclerosis.
    Mackenzie R; Kiernan M; McKenzie D; Youl BD
    J Clin Neurosci; 2006 Dec; 13(10):1033-6. PubMed ID: 16996272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-up study of hyper-immune goat serum (Aimspro) for amyotrophic lateral sclerosis (ALS).
    Mackenzie RA
    J Clin Neurosci; 2009 Nov; 16(11):1508-9. PubMed ID: 19700329
    [No Abstract]   [Full Text] [Related]  

  • 39. PARP activation and inflammatory reaction in selective neurodegeneration.
    Soós J
    Ideggyogy Sz; 2008 Mar; 61(3-4):136-9. PubMed ID: 18459454
    [No Abstract]   [Full Text] [Related]  

  • 40. Inflammatory processes in amyotrophic lateral sclerosis.
    McGeer PL; McGeer EG
    Muscle Nerve; 2002 Oct; 26(4):459-70. PubMed ID: 12362410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.